Jingyi Xie - Concepedia

Author

Jingyi Xie

University of Washington ORCID

Also Known As

J Y Xie, J. Xie, J.P. Xie, Jianpeng Zhang, Jing-Yi Xie, Jing-yi XIE, Jing-yi Xie, JingYi Xie, Jingbin Xie, Jingyi Xie

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

University of Washington Institute for Systems Biology Fred Hutch Cancer Center Swedish Medical Center Providence College

About

Jingyi Xie is an author at University of Washington specializing in medicine, immunology, and immune system.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	299
2	Immunology	6	6	299
3	Engineering	2	2	98
4	Biomedical Engineering	2	2	98
5	Allergy	1	1	15

Jingyi Xie

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Multiple early factors anticipate post-acute COVID-19 sequelae Yapeng Su, Dan Yuan, Daniel Chen, Cell	2022	1.1K
Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19 Yapeng Su, Daniel Chen, Dan Yuan, Cell	2020	625
Revealing the Immunogenic Risk of Polymers Bowen Li, Zhefan Yuan, Hsiang‐Chien Hung, Angewandte Chemie International Edition	2018	130
Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19 J. Lee, Yapeng Su, Priyanka Baloni, Nature Biotechnology Single Immune CellsMetabolic ChangesImmunologyImmune SurveillanceChronic Viral Infection	2021	117
Mitigation of Inflammatory Immune Responses with Hydrophilic Nanoparticles Bowen Li, Jingyi Xie, Zhefan Yuan, Angewandte Chemie International Edition NanoparticlesNanomedicineInflammationEthylene GlycolEngineering	2018	86
Zwitterionic Nanocages Overcome the Efficacy Loss of Biologic Drugs Bowen Li, Zhefan Yuan, Peng Zhang, Advanced Materials	2018	86
Infection in Southern Chinese Patients with Systemic Lupus Erythematosus: Spectrum, Drug Resistance, Outcomes, and Risk Factors Dongying Chen, Jingyi Xie, Haihong Chen, The Journal of Rheumatology	2016	55
Herpes zoster in patients with systemic lupus erythematosus: Clinical features, complications and risk factors Dongying Chen, Hao Li, Jingyi Xie, Experimental and Therapeutic Medicine	2017	45
HLA-A∗02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses Pavlo A. Nesterenko, Jami McLaughlin, Brandon L. Tsai, Cell Reports Viral PathogenesisImmunologyT Cell ReceptorsVirologyAntiviral Response	2021	35
Shared Antigen-specific CD8+ T cell Responses Against the SARS-COV-2 Spike Protein in HLA A*02:01 COVID-19 Participants William Chour, Alex M Xu, Alphonsus H. C. Ng, Immune System TrajectoriesAdaptive Immune SystemImmunologyAntiviral ResponseImmunodominance	2020	34

Page 1